Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fuji
McKinsey
Queensland Health
Baxter
Dow
Medtronic
Covington
Cantor Fitzgerald

Generated: October 18, 2018

DrugPatentWatch Database Preview

Dobutamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dobutamine hydrochloride and what is the scope of dobutamine hydrochloride freedom to operate?

Dobutamine hydrochloride is the generic ingredient in four branded drugs marketed by Baxter Hlthcare, Hospira, Luitpold, Teligent Pharma Inc, Teva Parenteral, Watson Labs, Watson Labs Inc, West-ward Pharms Int, and Lilly, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for dobutamine hydrochloride. Three suppliers are listed for this compound.

Pharmacology for dobutamine hydrochloride
Medical Subject Heading (MeSH) Categories for dobutamine hydrochloride
Synonyms for dobutamine hydrochloride
( inverted exclamation markA)-3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-|A-phenethylamine hydrochloride; 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride
( inverted question mark)-4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride
(.+-.)-4-[2-[[3-(p-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol hydrochloride
(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol hydrochloride
(+/-)-3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine hydrochloride
1, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride, (.+-.)-
1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride, (+-)-
1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride,(+-)-
1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1)
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine Hydrochloride
368D042
4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatecholhydrochloride
4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzol-1,2-diolhydrochlorid
4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol hydrochloride
4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol hydrochloride
4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride
4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]aminoethyl-1,2-benzenediol hydrochloride
4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol hydrochloride
4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride
49745-95-1
52663-81-7
A827836
AB0017762
AB1009505
AC-11653
AC1L231V
AC1Q3F7E
AK113122
AKOS015907731
AN-6582
AX8016940
BC202981
BG0171
BQKADKWNRWCIJL-UHFFFAOYSA-N
CC-27337
CCG-220352
CCG-221669
CHEBI:4671
CHEMBL1200418
CHM0029387
CS-3099
CTK1D5917
D 0676
D00632
D4335
DL-Dobutamine hydrochloride
Dobutamina clorhidrato [Spanish]
Dobutamine (hydrochloride)
Dobutamine Hcl
DOBUTAMINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER
Dobutamine hydrochloride (JP17/USP)
Dobutamine hydrochloride [USAN:BAN:JAN]
Dobutamine hydrochloride [USAN:USP:BAN:JAN]
Dobutamine hydrochloride in dextrose 5%
Dobutamine hydrochloride in dextrose 5% in plastic container
Dobutamine hydrochloride, >=98%
Dobutamine hydrochloride, British Pharmacopoeia (BP) Reference Standard
Dobutamine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Dobutamine hydrochloride, United States Pharmacopeia (USP) Reference Standard
DOBUTAMINEHYDROCHLORIDE
Dobutrex
Dobutrex (TN)
EINECS 256-464-1
EU-0100365
FT-0625557
FT-0681170
HMS1569G05
HY-15746
I14-2722
Inotrex
KB-289664
KS-000016OW
KS-1050
LP00365
LS-175120
LS-29983
LY 46236
LY-46236
MFCD00153795
MLS000860012
MLS001332503
MLS001332504
MLS002222253
MolPort-003-940-916
NCGC00093799-01
NCGC00093799-02
NCGC00261050-01
NSC 299583
NSC-299583
NSC299583
Posiject
Prestwick_741
Q711
rac Dobutamine Hydrochloride
REGID_for_CID_65324
S-1000
SCHEMBL41609
SMR000058435
SR-01000075265
SR-01000075265-1
ST51054789
Tox21_500365
TR-036978
W-106009

US Patents and Regulatory Information for dobutamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074995-001 Mar 31, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074114-001 Nov 30, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020255-001 Oct 19, 1993 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020255-004 Oct 19, 1993 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fuji
McKinsey
Queensland Health
Baxter
Dow
Medtronic
Covington
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.